Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Liberty Live-C
LLYVK
5
American Express
AXP
AU Stock MarketDetailed Quotes
MXCDA MGC Pharmaceuticals Ltd
- 0.475
- 0.0000.00%
20min DelayTrading Nov 7 16:00 AET
2.10MMarket Cap-0.07P/E (Static)
0.000High0.000Low0Volume0.000Open0.475Pre Close0.00Turnover0.47552wk High0.00%Turnover Ratio4.43MShares0.42052wk Low-7.1EPS TTM1.86MFloat Cap1.000Historical HighLossP/E (Static)3.92MShs Float0.410Historical Low-7.1EPS LYR0.00%Amplitude--Dividend TTM-0.28P/B1Lot Size--Div YieldTTM
About MGC Pharmaceuticals Ltd Company
No Data
Company Profile
SymbolMXCDA
Company NameMGC Pharmaceuticals Ltd
Share Registry--
Company Executives
- Name
- Position
- Salary
- Roby Zomer
- Executive Director,Managing Director and Chief Executive Officer
- 354.02K
- Dr. Stephen Barry Parker
- Non-Executive Director,Senior Independent Director and Interim Chairman
- 30.59K
- Layton Mills
- Non-Executive Director
- --
- Dr. Ross Walker
- Non-Executive Director,Head of Clinical Advisory Team
- 44.00K
- Rowan Harland
- Company Secretary
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting